Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 78 Records) |
| Query Trace: Coronary Artery Disease and PCSK9[original query] |
|---|
| PCSK9 loss of function is protective against extra-coronary atherosclerotic cardiovascular disease in a large multi-ethnic cohort. PloS one 2020 11 15 (11): e0239752. Small Aeron M, Huffman Jennifer E, Klarin Derek, Lynch Julie A, Assimes Themistocles, DuVall Scott, Sun Yan V, Shere Labiba, Natarajan Pradeep, Gaziano Michael, Rader Daniel J, Wilson Peter W F, Tsao Philip S, Chang Kyong-Mi, Cho Kelly, O'Donnell Christopher J, Casas Juan P, Damrauer Scott M, |
| PCSK9 Gene E670G Polymorphism and Coronary Artery Disease: An Updated Meta-Analysis of 5,484 Subjects. Frontiers in cardiovascular medicine 2020 11 7 582865. Li Yan-Yan, Wang Hui, Yang Xin-Xing, Geng Hong-Yu, Gong Ge, Lu Xin-Zhe |
| PCSK9 E670G (rs505151) Variant and Coronary Artery Disease Risk Among Diabetics. Genetic testing and molecular biomarkers 2021 9 25 (9): 615-623. Mohamed Samy H, Hassaan Mohamed M M, Ibrahim Basma A, Sabbah Norhan |
| Genetics, its role in preventing the pandemic of coronary artery disease. Clinical cardiology 2021 May . Roberts Robert, Fair Jacqu |
| Polymorphisms of rs2483205 and rs562556 in the PCSK9 gene are associated with coronary artery disease and cardiovascular risk factors. Scientific reports 2021 Jun 11 (1): 11450. Gai Min-Tao, Adi Dilare, Chen Xiao-Cui, Liu Fen, Xie Xiang, Yang Yi-Ning, Gao Xiao-Ming, Ma Xiang, Fu Zhen-Yan, Ma Yi-Tong, Chen Bang-Da |
| Variants of PCSK9 Gene Are Associated with Subclinical Atherosclerosis and Cardiometabolic Parameters in Mexicans. The GEA Project. Diagnostics (Basel, Switzerland) 2021 4 11 (5): . Zamarrón-Licona Erasmo, Rodríguez-Pérez José Manuel, Posadas-Sánchez Rosalinda, Vargas-Alarcón Gilberto, Baños-González Manuel Alfonso, Borgonio-Cuadra Verónica Marusa, Pérez-Hernández Nonanz |
| PCSK9 genetic (rs11591147) and epigenetic (DNA methylation) modifications associated with PCSK9 expression and serum proteins in CAD patients. The journal of gene medicine 2021 Apr e3346. Shyamala Nivas, Gundapaneni Kishore Kumar, Galimudi Rajesh Kumar, Tupurani Mohini Aiyengar, Padala Chiranjeevi, Puranam Kaushik, Kupsal Keerthi, Kummari Ramanjaneyulu, Gantala Srilatha Reddy, Nallamala Krishna Reddy, Sahu Sanjib K, Hanumanth Surekha Ra |
| Screening of PCSK9 and LDLR genetic variants in Familial Hypercholesterolemia (FH) patients in India. Journal of human genetics 2021 Apr . Reddy Lakshmi Lavanya, Shah Swarup A V, Ponde Chandrashekhar K, Dalal Jamshed J, Jatale Raj G, Dalal Reeta J, Rajani Rajesh M, Pillai Sudhir K, Vanjani Chander V, Ashavaid Tester |
| Mutational Spectrum of LDLR and PCSK9 Genes Identified in Iranian Patients With Premature Coronary Artery Disease and Familial Hypercholesterolemia. Frontiers in genetics 2021 3 12 625959. Moradi Arman, Maleki Majid, Ghaemmaghami Zahra, Khajali Zahra, Noohi Feridoun, Moghadam Maryam Hosseini, Kalyinia Samira, Mowla Seyed Javad, Seidah Nabil G, Malakootian Mahsh |
| Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia. Journal of translational medicine 2021 12 19 (1): 498. Liu Ming-Ming, Peng Jia, Guo Yuan-Lin, Zhu Cheng-Gang, Wu Na-Qiong, Xu Rui-Xia, Dong Qian, Li Jian-J |
Meta-GWAS of PCSK9 levels detects two novel loci at APOB and TM6SF2.
Human molecular genetics 2021 10 31 (6): 999-1011. Pott Janne, Gådin Jesper R, Theusch Elizabeth, Kleber Marcus E, Delgado Graciela E, Kirsten Holger, Hauck Stefanie M, Burkhardt Ralph, Scharnagl Hubert, Krauss Ronald M, Loeffler Markus, März Winfried, Thiery Joachim, Silveira Angela, Van't Hooft Ferdinand M, Scholz Mark |
| The impact of gene variants on the thickness and softness of the Achilles tendon in familial hypercholesterolemia. Atherosclerosis 2022 Oct 358 41-46. Michikura Masahito, Hori Mika, Ogura Masatsune, Hosoda Kiminori, Harada-Shiba Mari |
| The Influence of Treatment with PCSK9 Inhibitors and Variants in the CRP (rs1800947), TNFA (rs1800629), and IL6 (rs1800795) Genes on the Corresponding Inflammatory Markers in Patients with Very High Lipoprotein(a) Levels. Journal of cardiovascular development and disease 2022 5 9 (5): . Levstek Tina, Podkrajšek Nik, Rehberger Likozar Andreja, Šebeštjen Miran, Trebušak Podkrajšek Katari |
| Coronary Artery Disease Risk of Familial Hypercholesterolemia Genetic Variants Independent of Clinically Observed Longitudinal Cholesterol Exposure. Circulation. Genomic and precision medicine 2022 Feb CIRCGEN121003501. Clarke Shoa L, Tcheandjieu Catherine, Hilliard Austin T, Lee Kyung Min, Lynch Julie, Chang Kyong-Mi, Miller Donald, Knowles Joshua W, O'Donnell Christopher, Tsao Philip S, Rader Daniel J, Wilson Peter W, Sun Yan V, Gaziano J Michael, Assimes Themistocles L, |
| Increased Carotid Intima-Media Thickness in Asymptomatic Individuals Is Associated with the PCSK9 (rs2149041) Gene Polymorphism in the Mexican Mestizo Population: Results of the GEA Cohort. Life (Basel, Switzerland) 2022 10 12 (10): . Posadas-Sánchez Rosalinda, Vargas-Alarcón Gilberto, Pérez-Méndez Óscar, Pérez-Hernández Nonanzit, Rodríguez-Pérez José Manu |
| Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): Effects on coronary artery disease and ischemic stroke. Atherosclerosis 2022 10 361 41-46. De Marchis Gian Marco, Dittrich Tolga D, Malik Rainer, Zietz Annaelle V, Kriemler Lilian F, Ference Brian A, Dichgans Martin, Georgakis Marios |
| Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation.
PLoS biology 2022 2 20 (2): e3001547. Richardson Tom G, Leyden Genevieve M, Wang Qin, Bell Joshua A, Elsworth Benjamin, Davey Smith George, Holmes Michael |
| Genetic Testing Enables the Diagnosis of Familial Hypercholesterolemia Underdiagnosed by Clinical Criteria: Analysis of Japanese Early-Onset Coronary Artery Disease Patients. Cardiology research and practice 2023 5 2023 2236422. Hiroshi Miyama, Yoshinori Katsumata, Mizuki Momoi, Genki Ichihara, Taishi Fujisawa, Jin Endo, Takashi Kawakami, Masaharu Kataoka, Shinsuke Yuasa, Motoaki Sano, Kazuki Sato, Keiichi Fuku |
| Serum and genetic markers related to rapid clinical progression of coronary artery disease. Revista espanola de cardiologia (English ed.) 2023 5 . Tamara García-Camarero, Sara Remuzgo-Martínez, Fernanda Genre, Raquel López-Mejías, Verónica Pulito-Cueto, Gabriela Veiga, Dae-Hyun Lee Hwang, Fermín Sáinz Laso, Aritz Gil Ongay, Miguel Ángel González-Gay, José M de la Torre Hernánd |
| Dynamics of the personalities of PCSK9 on missense variants (rs505151 and rs562556) from elderly cohort studies in Brazil. Journal of biomolecular structure & dynamics 2023 4 1-9. Galvão Lopes Vitor, Fernandes de Oliveira Victor, Mendonça Munhoz Dati Livia, Naslavsky Michel Satya, Ferreira Glaucio Monteiro, Hirata Mario Hiroyu |
| E670G PCSK9 polymorphism in HeFH & CAD with diabetes: is the bridge to personalized therapy within reach? Frontiers in clinical diabetes and healthcare 2023 11 4 1277288. Rano Alieva, Aleksandr Shek, Alisher Abdullaev, Khurshid Fozilov, Shovkat Khoshimov, Guzal Abdullaeva, Dariya Zakirova, Rano Kurbanova, Lilia Kan, Andrey K |
| PCSK9 gene variations in the clinical setting of premature cardiovascular disease: A critical appraisal. International journal of cardiology 2024 7 413 132402. Rebeca Lorca, Andrea Aparicio, Luis Gutiérrez, Rut Álvarez-Velasco, Francisco González-Urbistondo, Isaac Pascual, Juan Gómez, Daniel Vazquez-Coto, Claudia Garcia-Lago, Pablo Avanzas, Eliecer Co |
| PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis. BMC musculoskeletal disorders 2024 7 25 (1): 548. Ding-Qiang Chen, Wen-Bin Xu, Ke-Yi Xiao, Zhi-Qiang Que, Jin-Yi Feng, Nai-Kun Sun, Di-Xin Cai, Gang R |
| Multi-biobank Mendelian randomization analyses identify opposing pathways in plasma low-density lipoprotein-cholesterol lowering and gallstone disease. European journal of epidemiology 2024 7 . Guoyi Yang, Amy M Mason, Dipender Gill, C Mary Schooling, Stephen Burge |
| Association between Apo B, LDL-R and PCSK9 gene polymorphisms with coronary artery diseases in Egyptians. Molecular biology reports 2024 6 51 (1): 752. Nancy Mahsoub, Ahmed Almenshawy, Ahmed Mohammad Taki Eldin, Nehal M Abdel Hay, Amany R Youssef, Reham M El-Farahaty, Kefaya El-Sayed, Adel Mohamad Osman, Eman S Elhenna |
| Association of genetic variants related to combined lipid-lowering and antihypertensive therapies with risk of cardiovascular disease: 2?×?2 factorial Mendelian randomization analyses. BMC medicine 2024 5 22 (1): 201. Ying Li, Hongwei Liu, Chong Shen, Jianxin Li, Fangchao Liu, Keyong Huang, Dongfeng Gu, Yun Li, Xiangfeng |
| Association of lipid-lowering drugs with the risk of type 2 diabetes and its complications: a mendelian randomized study. Diabetology & metabolic syndrome 2024 10 16 (1): 240. Yue-Yang Zhang, Bing-Xue Chen, Qin W |
| A Case of Multiple Intracranial Major Artery Stenoses With Coexisting PCSK9 p.E32K and RNF213 p.R4810K Variants. Neurology. Genetics 2024 1 9 (5): e200099. Kotaro Noda, Yorito Hattori, Mika Hori, Mariko Harada-Shiba, Masafumi Iha |
| Identifying genetic susceptibility loci associated with human coronary artery disease. PloS one 2025 1 20 (1): e0315460. Aqsa Zahid, Andleeb Batool, Abdul Wajid, Yurong Wu, Chun Liang, Muhammad Ajmal Khan, Amin Ullah, Kashif Iqbal Sahibzada, Hong X |
| Genetic Predisposition to Low-Density Lipoprotein Cholesterol and Incident Type 2 Diabetes. JAMA cardiology 2025 1 . Akshaya Ravi, Satoshi Koyama, So Mi Jemma Cho, Sara Haidermota, Whitney Hornsby, Patrick T Ellinor, Pradeep Nataraj |
- Page last reviewed:Feb 1, 2024
- Content source: